1. Home
  2. ABT vs PFE Comparison

ABT vs PFE Comparison

Compare ABT & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABT

Abbott Laboratories

HOLD

Current Price

$104.15

Market Cap

183.3B

Sector

Health Care

ML Signal

HOLD

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$27.07

Market Cap

155.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABT
PFE
Founded
1888
1849
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.3B
155.2B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
ABT
PFE
Price
$104.15
$27.07
Analyst Decision
Strong Buy
Hold
Analyst Count
16
13
Target Price
$139.38
$28.23
AVG Volume (30 Days)
6.9M
32.3M
Earning Date
04-16-2026
05-05-2026
Dividend Yield
2.41%
6.24%
EPS Growth
N/A
N/A
EPS
3.72
1.36
Revenue
$44,328,000,000.00
$62,579,000,000.00
Revenue This Year
$8.90
N/A
Revenue Next Year
$7.39
N/A
P/E Ratio
$28.10
$20.23
Revenue Growth
5.67
N/A
52 Week Low
$102.41
$20.92
52 Week High
$137.49
$27.94

Technical Indicators

Market Signals
Indicator
ABT
PFE
Relative Strength Index (RSI) 32.67 50.39
Support Level N/A $26.29
Resistance Level $112.81 $27.70
Average True Range (ATR) 2.11 0.59
MACD -0.44 0.00
Stochastic Oscillator 17.88 43.59

Price Performance

Historical Comparison
ABT
PFE

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Share on Social Networks: